Last 12 months
Inside the activity.
0 purchase rows · 2 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 1 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 15, 2026 Filed Aug 18, 2026 20:13 UTC |
Crouse Steven C.President - Diag & Spatial Bi
|
Exercise / conversionRestricted Stock Units · Derivative | 1,868 | $0.00 | $0.00 |
DisclosureSEC source: 0000914190-26-000114 · form4.xml · derivative · entry 6 Crouse Steven C. · CIK 0002065241 · President - Diag & Spatial Bi 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,869 Underlying: Common Stock · 1,868 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. F5 · derivative.exercise_date: 1,868 restricted stock units vest on 8/15/2026 and 1,869 restricted stock units vest on 8/15/2027. F5 · derivative.expiration_date: 1,868 restricted stock units vest on 8/15/2026 and 1,869 restricted stock units vest on 8/15/2027. Read SEC document |
| August 15, 2026 Filed Aug 18, 2026 20:13 UTC |
Crouse Steven C.President - Diag & Spatial Bi
|
Exercise / conversionRestricted Stock Units · Derivative | 1,379 | $0.00 | $0.00 |
DisclosureSEC source: 0000914190-26-000114 · form4.xml · derivative · entry 5 Crouse Steven C. · CIK 0002065241 · President - Diag & Spatial Bi 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,379 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. F4 · derivative.exercise_date: 1,379 restricted stock units vest on 8/15/2026. F4 · derivative.expiration_date: 1,379 restricted stock units vest on 8/15/2026. Read SEC document |
| August 15, 2026 Filed Aug 18, 2026 20:13 UTC |
Crouse Steven C.President - Diag & Spatial Bi
|
Tax withholdingCommon Stock | 1,947 | $72.40 | $140,962.80 |
DisclosureSEC source: 0000914190-26-000114 · form4.xml · nonDerivative · entry 2 Crouse Steven C. · CIK 0002065241 · President - Diag & Spatial Bi 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,237 Read SEC document |
| August 15, 2026 Filed Aug 18, 2026 20:13 UTC |
Crouse Steven C.President - Diag & Spatial Bi
|
Exercise / conversionCommon Stock | 5,423 | $0.00 | $0.00 |
DisclosureSEC source: 0000914190-26-000114 · form4.xml · nonDerivative · entry 1 Crouse Steven C. · CIK 0002065241 · President - Diag & Spatial Bi 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,184 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 15, 2026 Filed Aug 18, 2026 20:12 UTC |
Herr Amy E.Director
|
Exercise / conversionRestricted Stock Units · Derivative | 311 | $0.00 | $0.00 |
DisclosureSEC source: 0000914190-26-000113 · form4.xml · derivative · entry 15 Herr Amy E. · CIK 0002055523 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By significant other Disclosed balance after: 621 Underlying: Common Stock · 311 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. F11 · derivative.exercise_date: 311 restricted stock units vest on each of 8/15/2026 and 8/15/2027, and 310 restricted stock units vest on 8/15/2028. F11 · derivative.expiration_date: 311 restricted stock units vest on each of 8/15/2026 and 8/15/2027, and 310 restricted stock units vest on 8/15/2028. Read SEC document |
| August 15, 2026 Filed Aug 18, 2026 20:12 UTC |
Herr Amy E.Director
|
Exercise / conversionRestricted Stock Units · Derivative | 160 | $0.00 | $0.00 |
DisclosureSEC source: 0000914190-26-000113 · form4.xml · derivative · entry 13 Herr Amy E. · CIK 0002055523 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By significant other Disclosed balance after: 160 Underlying: Common Stock · 160 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. F9 · derivative.exercise_date: 160 restricted stock units vest on each of 8/15/2026 and 8/15/2027. F9 · derivative.expiration_date: 160 restricted stock units vest on each of 8/15/2026 and 8/15/2027. Read SEC document |
| August 15, 2026 Filed Aug 18, 2026 20:12 UTC |
Herr Amy E.Director
|
Exercise / conversionRestricted Stock Units · Derivative | 118 | $0.00 | $0.00 |
DisclosureSEC source: 0000914190-26-000113 · form4.xml · derivative · entry 12 Herr Amy E. · CIK 0002055523 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By significant other Disclosed balance after: 0 Underlying: Common Stock · 118 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. F8 · derivative.exercise_date: 118 restricted stock units vest on 8/15/2026. F8 · derivative.expiration_date: 118 restricted stock units vest on 8/15/2026. Read SEC document |
| August 15, 2026 Filed Aug 18, 2026 20:12 UTC |
Herr Amy E.Director
|
Tax withholdingCommon Stock | 213 | $72.40 | $15,421.20 |
DisclosureSEC source: 0000914190-26-000113 · form4.xml · nonDerivative · entry 3 Herr Amy E. · CIK 0002055523 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By significant other Disclosed balance after: 576 Read SEC document |
| August 15, 2026 Filed Aug 18, 2026 20:12 UTC |
Herr Amy E.Director
|
Exercise / conversionCommon Stock | 589 | $0.00 | $0.00 |
DisclosureSEC source: 0000914190-26-000113 · form4.xml · nonDerivative · entry 2 Herr Amy E. · CIK 0002055523 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By significant other Disclosed balance after: 789 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 29, 2026 Filed Jul 31, 2026 21:18 UTC |
Hippel JamesCFO
|
Exercise / conversionStock Options (Right to Buy) · Derivative | 62,068 | $0.00 Strike: $47.60 | $0.00 |
DisclosureSEC source: 0000914190-26-000108 · form4.xml · derivative · entry 3 Hippel James · CIK 0001603594 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 62,068 shares Expires 2026-08-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Fully exercisable. Read SEC document |
| July 29, 2026 Filed Jul 31, 2026 21:18 UTC |
Hippel JamesCFO
|
Tax withholdingCommon Stock | 51,024 | $72.03 | $3,675,258.72 |
DisclosureSEC source: 0000914190-26-000108 · form4.xml · nonDerivative · entry 2 Hippel James · CIK 0001603594 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 164,714 Read SEC document |
| July 29, 2026 Filed Jul 31, 2026 21:18 UTC |
Hippel JamesCFO
|
Exercise / conversionCommon Stock | 62,068 | $47.60 | $2,954,436.80 |
DisclosureSEC source: 0000914190-26-000108 · form4.xml · nonDerivative · entry 1 Hippel James · CIK 0001603594 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 215,738 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 28, 2026 Filed Jul 30, 2026 20:11 UTC |
Kelderman KimDirector · Chief Executive Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 35,000 | $0.00 Strike: $47.60 | $0.00 |
DisclosureSEC source: 0000914190-26-000106 · form4.xml · derivative · entry 3 Kelderman Kim · CIK 0001739054 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 35,000 shares Expires 2026-08-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Fully exercisable. Read SEC document |
| July 28, 2026 Filed Jul 30, 2026 20:11 UTC |
Kelderman KimDirector · Chief Executive Officer
|
Tax withholdingCommon Stock | 28,686 | $72.07 | $2,067,400.02 |
DisclosureSEC source: 0000914190-26-000106 · form4.xml · nonDerivative · entry 2 Kelderman Kim · CIK 0001739054 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 72,113 Read SEC document |
| July 28, 2026 Filed Jul 30, 2026 20:11 UTC |
Kelderman KimDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 35,000 | $47.60 | $1,666,000.00 |
DisclosureSEC source: 0000914190-26-000106 · form4.xml · nonDerivative · entry 1 Kelderman Kim · CIK 0001739054 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,799 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 23, 2026 Filed Jul 27, 2026 20:03 UTC |
Bohnen ShaneSVP - General Counsel
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 448 | $0.00 Strike: $47.60 | $0.00 |
DisclosureSEC source: 0000914190-26-000104 · form4.xml · derivative · entry 3 Bohnen Shane · CIK 0001969581 · SVP - General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 448 shares Expires 2026-08-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Fully exercisable. Read SEC document |
| July 23, 2026 Filed Jul 27, 2026 20:03 UTC |
Bohnen ShaneSVP - General Counsel
|
Tax withholdingCommon Stock | 344 | $71.77 | $24,688.88 |
DisclosureSEC source: 0000914190-26-000104 · form4.xml · nonDerivative · entry 2 Bohnen Shane · CIK 0001969581 · SVP - General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,353 Read SEC document |
| July 23, 2026 Filed Jul 27, 2026 20:03 UTC |
Bohnen ShaneSVP - General Counsel
|
Exercise / conversionCommon Stock | 448 | $47.60 | $21,324.80 |
DisclosureSEC source: 0000914190-26-000104 · form4.xml · nonDerivative · entry 1 Bohnen Shane · CIK 0001969581 · SVP - General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,697 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 02, 2026 Filed Jun 4, 2026 20:28 UTC |
Crouse Steven C.President - Diag & Spatial Bi
|
Exercise / conversionRestricted Stock Units · Derivative | 600 | $0.00 | $0.00 |
DisclosureSEC source: 0000914190-26-000096 · form4.xml · derivative · entry 4 Crouse Steven C. · CIK 0002065241 · President - Diag & Spatial Bi 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,200 Underlying: Common Stock · 600 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. F3 · derivative.exercise_date: 600 restricted stock units vest on each of 6/2/2026, 6/2/2027 and 6/2/2028. F3 · derivative.expiration_date: 600 restricted stock units vest on each of 6/2/2026, 6/2/2027 and 6/2/2028. Read SEC document |
| June 02, 2026 Filed Jun 4, 2026 20:28 UTC |
Crouse Steven C.President - Diag & Spatial Bi
|
Tax withholdingCommon Stock | 216 | $49.77 | $10,750.32 |
DisclosureSEC source: 0000914190-26-000096 · form4.xml · nonDerivative · entry 2 Crouse Steven C. · CIK 0002065241 · President - Diag & Spatial Bi 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,761 Read SEC document |
| June 02, 2026 Filed Jun 4, 2026 20:28 UTC |
Crouse Steven C.President - Diag & Spatial Bi
|
Exercise / conversionCommon Stock | 600 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000914190-26-000096 · form4.xml · nonDerivative · entry 1 Crouse Steven C. · CIK 0002065241 · President - Diag & Spatial Bi 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,977 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. F17 · balance_after: Due to a mathematical error on the Form 4 filed May 5, 2026, the number of shares beneficially owned is being increased by 40 shares and this filing represents the correct number of shares beneficially owned by the Reporting Person. Read SEC document |
| May 08, 2026 Filed May 12, 2026 20:04 UTC |
Herr Amy E.Director
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 6,636 | $0.00 Strike: $47.60 | $0.00 |
DisclosureSEC source: 0000914190-26-000092 · form4.xml · derivative · entry 6 Herr Amy E. · CIK 0002055523 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By significant other Disclosed balance after: 0 Underlying: Common Stock · 6,636 shares Expires 2026-08-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Fully vested. Read SEC document |
| May 08, 2026 Filed May 12, 2026 20:04 UTC |
Herr Amy E.Director
|
SaleCommon Stock | 6,636 | $48.28 | $320,386.08 |
DisclosureSEC source: 0000914190-26-000092 · form4.xml · nonDerivative · entry 3 Herr Amy E. · CIK 0002055523 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By significant other Disclosed balance after: 200 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.19 to $48.31, inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 08, 2026 Filed May 12, 2026 20:04 UTC |
Herr Amy E.Director
|
Exercise / conversionCommon Stock | 6,636 | $47.60 | $315,873.60 |
DisclosureSEC source: 0000914190-26-000092 · form4.xml · nonDerivative · entry 2 Herr Amy E. · CIK 0002055523 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By significant other Disclosed balance after: 6,836 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 05, 2026 Filed May 7, 2026 21:24 UTC |
Bohnen ShaneSVP - General Counsel
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 8,400 | $0.00 Strike: $47.60 | $0.00 |
DisclosureSEC source: 0000914190-26-000089 · form4.xml · derivative · entry 3 Bohnen Shane · CIK 0001969581 · SVP - General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 448 Underlying: Common Stock · 8,400 shares Expires 2026-08-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Fully exercisable. Read SEC document |
| May 05, 2026 Filed May 7, 2026 21:24 UTC |
Bohnen ShaneSVP - General Counsel
|
Tax withholdingCommon Stock | 7,055 | $56.68 | $399,877.40 |
DisclosureSEC source: 0000914190-26-000089 · form4.xml · nonDerivative · entry 2 Bohnen Shane · CIK 0001969581 · SVP - General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,249 Read SEC document |
| May 05, 2026 Filed May 7, 2026 21:24 UTC |
Bohnen ShaneSVP - General Counsel
|
Exercise / conversionCommon Stock | 8,400 | $47.60 | $399,840.00 |
DisclosureSEC source: 0000914190-26-000089 · form4.xml · nonDerivative · entry 1 Bohnen Shane · CIK 0001969581 · SVP - General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,304 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 05, 2026 Filed May 7, 2026 21:26 UTC |
Hippel JamesCFO
|
Exercise / conversionStock Options (Right to Buy) · Derivative | 62,000 | $0.00 Strike: $47.60 | $0.00 |
DisclosureSEC source: 0000914190-26-000090 · form4.xml · derivative · entry 3 Hippel James · CIK 0001603594 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,068 Underlying: Common Stock · 62,000 shares Expires 2026-08-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Fully exercisable. Read SEC document |
| May 05, 2026 Filed May 7, 2026 21:26 UTC |
Hippel JamesCFO
|
Tax withholdingCommon Stock | 56,955 | $56.68 | $3,228,209.40 |
DisclosureSEC source: 0000914190-26-000090 · form4.xml · nonDerivative · entry 2 Hippel James · CIK 0001603594 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 153,670 Read SEC document |
| May 05, 2026 Filed May 7, 2026 21:26 UTC |
Hippel JamesCFO
|
Exercise / conversionCommon Stock | 62,000 | $47.60 | $2,951,200.00 |
DisclosureSEC source: 0000914190-26-000090 · form4.xml · nonDerivative · entry 1 Hippel James · CIK 0001603594 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 210,625 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 05, 2026 Filed May 7, 2026 21:22 UTC |
Kelderman KimDirector · Chief Executive Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 26,692 | $0.00 Strike: $47.60 | $0.00 |
DisclosureSEC source: 0000914190-26-000088 · form4.xml · derivative · entry 3 Kelderman Kim · CIK 0001739054 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 26,692 shares Expires 2026-08-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Fully exercisable. Read SEC document |
| May 05, 2026 Filed May 7, 2026 21:22 UTC |
Kelderman KimDirector · Chief Executive Officer
|
Tax withholdingCommon Stock | 23,951 | $56.68 | $1,357,542.68 |
DisclosureSEC source: 0000914190-26-000088 · form4.xml · nonDerivative · entry 2 Kelderman Kim · CIK 0001739054 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 65,799 Read SEC document |
| May 05, 2026 Filed May 7, 2026 21:22 UTC |
Kelderman KimDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 26,692 | $47.60 | $1,270,539.20 |
DisclosureSEC source: 0000914190-26-000088 · form4.xml · nonDerivative · entry 1 Kelderman Kim · CIK 0001739054 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 89,750 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 01, 2026 Filed May 5, 2026 20:12 UTC |
Crouse Steven C.President - Diag & Spatial Bi
|
Exercise / conversionRestricted Stock Units · Derivative | 794 | $0.00 | $0.00 |
DisclosureSEC source: 0000914190-26-000083 · form4.xml · derivative · entry 3 Crouse Steven C. · CIK 0002065241 · President - Diag & Spatial Bi 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 794 Underlying: Common Stock · 794 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. F2 · derivative.exercise_date: 794 restricted stock units vest on 5/1/2026 and 5/1/2027. F2 · derivative.expiration_date: 794 restricted stock units vest on 5/1/2026 and 5/1/2027. Read SEC document |
| May 01, 2026 Filed May 5, 2026 20:12 UTC |
Crouse Steven C.President - Diag & Spatial Bi
|
Tax withholdingCommon Stock | 311 | $55.02 | $17,111.22 |
DisclosureSEC source: 0000914190-26-000083 · form4.xml · nonDerivative · entry 2 Crouse Steven C. · CIK 0002065241 · President - Diag & Spatial Bi 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,337 Read SEC document |
| May 01, 2026 Filed May 5, 2026 20:12 UTC |
Crouse Steven C.President - Diag & Spatial Bi
|
Exercise / conversionCommon Stock | 794 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000914190-26-000083 · form4.xml · nonDerivative · entry 1 Crouse Steven C. · CIK 0002065241 · President - Diag & Spatial Bi 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,688 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. Read SEC document |
| April 22, 2026 Filed Apr 24, 2026 22:06 UTC |
Kelderman KimDirector · Chief Executive Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 11,344 | $0.00 Strike: $47.60 | $0.00 |
DisclosureSEC source: 0000914190-26-000081 · form4.xml · derivative · entry 3 Kelderman Kim · CIK 0001739054 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 61,692 Underlying: Common Stock · 11,344 shares Expires 2026-08-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Fully exercisable. Read SEC document |
| April 22, 2026 Filed Apr 24, 2026 22:06 UTC |
Kelderman KimDirector · Chief Executive Officer
|
Tax withholdingCommon Stock | 1,363 | $58.58 | $79,844.54 |
DisclosureSEC source: 0000914190-26-000081 · form4.xml · nonDerivative · entry 2 Kelderman Kim · CIK 0001739054 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 63,058 Read SEC document |
| April 22, 2026 Filed Apr 24, 2026 22:06 UTC |
Kelderman KimDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 11,344 | $0.00 | $0.00 |
DisclosureSEC source: 0000914190-26-000081 · form4.xml · nonDerivative · entry 1 Kelderman Kim · CIK 0001739054 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 64,421 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 22, 2026 Filed Apr 24, 2026 22:05 UTC |
Hippel JamesCFO
|
Exercise / conversionStock Options (Right to Buy) · Derivative | 62,000 | $0.00 Strike: $47.60 | $0.00 |
DisclosureSEC source: 0000914190-26-000080 · form4.xml · derivative · entry 3 Hippel James · CIK 0001603594 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 124,068 Underlying: Common Stock · 62,000 shares Expires 2026-08-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Fully exercisable. Read SEC document |
| April 22, 2026 Filed Apr 24, 2026 22:05 UTC |
Hippel JamesCFO
|
Tax withholdingCommon Stock | 56,097 | $58.58 | $3,286,162.26 |
DisclosureSEC source: 0000914190-26-000080 · form4.xml · nonDerivative · entry 2 Hippel James · CIK 0001603594 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 148,625 Read SEC document |
| April 22, 2026 Filed Apr 24, 2026 22:05 UTC |
Hippel JamesCFO
|
Exercise / conversionCommon Stock | 62,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000914190-26-000080 · form4.xml · nonDerivative · entry 1 Hippel James · CIK 0001603594 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 204,722 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 14, 2026 Filed Apr 16, 2026 20:19 UTC |
Kelderman KimDirector · Chief Executive Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 36,500 | $0.00 Strike: $47.60 | $0.00 |
DisclosureSEC source: 0000914190-26-000070 · form4.xml · derivative · entry 3 Kelderman Kim · CIK 0001739054 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 73,036 Underlying: Common Stock · 36,500 shares Expires 2026-08-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Fully exercisable. Read SEC document |
| April 14, 2026 Filed Apr 16, 2026 20:19 UTC |
Kelderman KimDirector · Chief Executive Officer
|
Tax withholdingCommon Stock | 32,088 | $58.66 | $1,882,282.08 |
DisclosureSEC source: 0000914190-26-000070 · form4.xml · nonDerivative · entry 2 Kelderman Kim · CIK 0001739054 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,077 Read SEC document |
| April 14, 2026 Filed Apr 16, 2026 20:19 UTC |
Kelderman KimDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 36,500 | $0.00 | $0.00 |
DisclosureSEC source: 0000914190-26-000070 · form4.xml · nonDerivative · entry 1 Kelderman Kim · CIK 0001739054 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 85,165 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 03, 2026 Filed Apr 7, 2026 20:59 UTC |
Bohnen ShaneSVP - General Counsel
|
Exercise / conversionRestricted Stock Units · Derivative | 2,259 | $0.00 | $0.00 |
DisclosureSEC source: 0000914190-26-000067 · form4.xml · derivative · entry 8 Bohnen Shane · CIK 0001969581 · SVP - General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,259 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. F5 · derivative.exercise_date: 2,259 restricted stock units vest on 4/3/2026. F5 · derivative.expiration_date: 2,259 restricted stock units vest on 4/3/2026. Read SEC document |
| April 03, 2026 Filed Apr 7, 2026 20:59 UTC |
Bohnen ShaneSVP - General Counsel
|
Tax withholdingCommon Stock | 740 | $53.13 | $39,316.20 |
DisclosureSEC source: 0000914190-26-000067 · form4.xml · nonDerivative · entry 2 Bohnen Shane · CIK 0001969581 · SVP - General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,904 Read SEC document |
| April 03, 2026 Filed Apr 7, 2026 20:59 UTC |
Bohnen ShaneSVP - General Counsel
|
Exercise / conversionCommon Stock | 2,259 | $0.00 | $0.00 |
DisclosureSEC source: 0000914190-26-000067 · form4.xml · nonDerivative · entry 1 Bohnen Shane · CIK 0001969581 · SVP - General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,644 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 23:48 UTC |
Crouse Steven C.President - Diag & Spatial Bi
|
GrantStock Option (right to buy) · Derivative | 1,911 | $0.00 Strike: $57.82 | $0.00 |
DisclosureSEC source: 0000914190-26-000036 · form4.xml · derivative · entry 17 Crouse Steven C. · CIK 0002065241 · President - Diag & Spatial Bi 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,911 Underlying: Common Stock · 1,911 shares Expires 2036-03-02 F16 · derivative.exercise_date: Options to purchase 478 shares vest on each of 3/2/2027, 3/2/2028 and 3/2/2030; and options to purchase 477 shares vest on 3/2/2029. Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 23:48 UTC |
Crouse Steven C.President - Diag & Spatial Bi
|
GrantRestricted Stock Units · Derivative | 735 | $0.00 | $0.00 |
DisclosureSEC source: 0000914190-26-000036 · form4.xml · derivative · entry 16 Crouse Steven C. · CIK 0002065241 · President - Diag & Spatial Bi 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 735 Underlying: Common Stock · 735 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. F15 · derivative.exercise_date: 245 restricted stock units vest on 3/2/2027, 3/2/2028 and 3/2/2029. F15 · derivative.expiration_date: 245 restricted stock units vest on 3/2/2027, 3/2/2028 and 3/2/2029. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.